3D Systems Corporation (BIT:1DDD)

Market Cap	250.48M
Revenue (ttm)	351.96M
Net Income (ttm)	-123.27M
Shares Out	n/a
EPS (ttm)	-0.93
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,020
Average Volume	4,857
Open	1.510
Previous Close	1.374
Day's Range	1.471 - 1.510
52-Week Range	1.197 - 4.628
Beta	n/a
RSI	71.84
Earnings Date	Aug 11, 2025

About Ligand Pharmaceuticals

3D Systems Corporation provides 3D printing and digital manufacturing solutions in North and South America, Europe, the Middle East, Africa, the Asia Pacific, and Oceania. It operates through two segments, Healthcare Solutions and Industrial Solutions. The company offers 3D printing technologies, including stereolithography (SLA), selective laser sintering, direct metal printing, MultiJet printing, ColorJet printing, polymer extrusion, and extrusion and SLA based bioprinting. Its print materials include plastic, nylon, metal, composite, elastom...

• Industry: Special Industry Machinery, not elsewhere classified
• Founded: 1986
• Employees: 1,833
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1DDD

Financial Performance

In 2024, 3D Systems's revenue was $440.12 million, a decrease of -9.82% compared to the previous year's $488.07 million. Losses were -$255.65 million, -29.60% less than in 2023.